Consun Pharmaceutical Group Limited

SEHK:1681 Voorraadrapport

Marktkapitalisatie: HK$6.8b

Consun Pharmaceutical Group Toekomstige groei

Future criteriumcontroles 4/6

Consun Pharmaceutical Group zal naar verwachting groeien in winst en omzet met respectievelijk 14.9% en 13.5% per jaar. De winst per aandeel zal naar verwachting groeien met 14.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 24.1% zijn.

Belangrijke informatie

14.9%

Groei van de winst

14.4%

Groei van de winst per aandeel

Pharmaceuticals winstgroei10.8%
Inkomstengroei13.5%
Toekomstig rendement op eigen vermogen24.1%
Dekking van analisten

Low

Laatst bijgewerkt14 Oct 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story

Oct 02
Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story

Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors

Sep 26
Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Jun 12
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

May 12
Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30

Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Jun 01
Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

May 04
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Apr 28
Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Apr 07
Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Aug 26
Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Apr 21
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Mar 17
Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

Feb 19
Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 29
How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Jan 08
Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Dec 18
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

Nov 18
Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

Winst- en omzetgroeiprognoses

SEHK:1681 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20263,8321,213N/A1,2492
12/31/20253,3521,056N/A1,0982
12/31/20242,948915N/A9532
6/30/20242,739836833915N/A
3/31/20242,665810800867N/A
12/31/20232,590785766819N/A
9/30/20232,528759797844N/A
6/30/20232,466734828869N/A
3/31/20232,403708862908N/A
12/31/20222,340683896948N/A
9/30/20222,246660836906N/A
6/30/20222,152636776865N/A
3/31/20222,098613701795N/A
12/31/20212,045590627726N/A
9/30/20211,959565655731N/A
6/30/20211,874541683737N/A
3/31/20211,813520748802N/A
12/31/20201,753499813867N/A
9/30/20201,653269639717N/A
6/30/20201,55339465567N/A
3/31/20201,64160334475N/A
12/31/20191,72880203383N/A
9/30/20191,822288231442N/A
6/30/20191,916496259501N/A
3/31/20191,880481410628N/A
12/31/20181,844465561754N/A
9/30/20181,802448519662N/A
6/30/20181,760430476570N/A
3/31/20181,710413N/A411N/A
12/31/20171,660396N/A252N/A
9/30/20171,601372N/A323N/A
6/30/20171,541347N/A393N/A
3/31/20171,382327N/A421N/A
12/31/20161,223308N/A449N/A
9/30/20161,060291N/A362N/A
6/30/2016896274N/A275N/A
3/31/2016863262N/A230N/A
12/31/2015831250N/A184N/A
9/30/2015814246N/A180N/A
6/30/2015798242N/A175N/A
3/31/2015764226N/A235N/A
12/31/2014731211N/A295N/A
9/30/2014697198N/A285N/A
6/30/2014664185N/A275N/A
3/31/2014618169N/A219N/A
12/31/2013572153N/A164N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 1681 ( 14.9% per jaar) ligt boven de spaarquote ( 2.3% ).

Winst versus markt: De winst van 1681 ( 14.9% per jaar) zal naar verwachting sneller groeien dan de Hong Kong markt ( 11.6% per jaar).

Hoge groeiwinsten: De winst van 1681 zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van 1681 ( 13.5% per jaar) zal naar verwachting sneller groeien dan de markt Hong Kong ( 7.8% per jaar).

Hoge groei-inkomsten: De omzet van 1681 ( 13.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen 1681 zal naar verwachting over 3 jaar hoog zijn ( 24.1 %)


Ontdek groeibedrijven